IN8BIO INC. - COMMON
0.2550
07-October-24 14:59:48
15 minutes delayed
Stocks
-0.0083
-3.15%
Today's range
0.2402 - 0.2760
ISIN
N/A
Source
NASDAQ
-
IN8bio Announces Pricing of $12.4 Million Private Placement
01 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia
04 Sep 2024 15:01:00 By Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
29 Aug 2024 05:05:00 By Nasdaq GlobeNewswire
-
IN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
08 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
24 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
13 Jun 2024 15:01:00 By Nasdaq GlobeNewswire
-
03 Jun 2024 05:05:00 By Nasdaq GlobeNewswire
-
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
24 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
23 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
14 May 2024 09:00:00 By Nasdaq GlobeNewswire
-
13 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
09 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
30 Apr 2024 05:05:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
16 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
09 Apr 2024 15:30:00 By Nasdaq GlobeNewswire
-
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
14 Mar 2024 15:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 15:30:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >